Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Definium Therapeutics Insider Sold Shares Worth $1,153,784, According to a Recent SEC Filing

Definium Therapeutics Insider Sold Shares Worth $1,153,784, According to a Recent SEC Filing

MT newswireMT newswire2026/09/30 08:02
04:02 AM EDT, 09/30/2026 (MT Newswires) -- Robert Barrow, Director, Chief Executive Officer, on September 25, 2026, sold 31,550 shares in Definium Therapeutics (DFTX) for $1,153,784. Following the Form 4 filing with the SEC, Barrow has control over a total of 2,213,090 common shares of the company, with 2,213,090 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1813814/000110465926112062/xslF345X05/tm2626627-4_4seq1.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!